One of the largest managers of pharmaceutical benefits in the U.S. says it will start limiting the duration and dose of some prescriptions for opioid painkillers, in an effort to combat widespread addiction.
from WSJ.com: US Business http://ift.tt/2wB4q9U
via IFTTT
No comments:
Post a Comment